Kazia Annual Report 2022

71 Kazia Theraputics Limited Annual Report 2022 2022 at a Glance Chairman’s Letter CEO’s Report Key Milestones Pipeline Review ESG Financial Reports Note 33. Share-based payments continued 2022 Tranche Grant date Expiry date Exercise price Balance at the start of the year Granted Exercised Expired / lapsed on termination of employment Balance at the end of the year 1 5/09/2016 5/09/2021 $1.6300 50,000 - - (50,000) - 2 12/10/2016 17/10/2021 $1.5600 62,000 - - (62,000) - 3 31/10/2016 1/11/2021 $1.3800 12,500 - - (12,500) - 4 21/11/2016 23/11/2021 $1.3800 50,000 - - (50,000) - 5 7/08/2017 7/08/2022 $0.6700 87,000 - (25,000) (46,500) 15,500 6 5/02/2018 5/02/2023 $0.7800 320,000 - - (80,000) 240,000 7 4/01/2019 4/01/2024 $0.4925 37,500 - - (37,500) - 8 13/11/2019 13/11/2023 $0.4925 1,200,000 - - - 1,200,000 9 13/01/2020 13/01/2025 $0.8812 200,000 - - - 200,000 10 9/11/2020 9/11/2024 $1.1320 1,200,000 - - - 1,200,000 11 9/11/2020 9/11/2024 $0.8812 800,000 - - - 800,000 12 4/01/2021 4/01/2026 $1.6900 200,000 - - - 200,000 13 9/09/2021 26/06/2026 $1.3700 - 100,000 - - 100,000 14 16/11/2021 16/11/2025 $1.6900 - 1,000,000 - - 1,000,000 15 16/11/2021 16/11/2025 $2.2400 - 1,500,000 - - 1,500,000 16 16/11/2021 16/11/2025 $1.5600 - 800,000 - - 800,000 17 1/02/2022 1/02/2027 $0.9400 - 500,000 - - 500,000 18 1/02/2022 1/02/2027 $0.9400 - 800,000 - - 800,000 19 24/05/2022 24/05/2027 $0.7800 - 100,000 - - 100,000 4,219,000 4,800,000 (25,000) (338,500) 8,655,500 Weighted average exercise price $0.8911 $1.6110 $0.6700 $1.1123 $1.2826 At the end of the period the following outstanding options were vested and exercisable: • Options in tranche 1 - 4 expired during the year • Options in tranches 1 - 8 were vested and exercisable, apart from those in the above table which have expired • Options in tranches 9 - 10 were vested and exercisable as to 50% • Options in tranche 11 were vested and exercisable as to 75% • Options in tranches 12 - 14 were vested and exercisable as to 25% • Options in tranches 15 - 19 were unvested The weighted average remaining contractual life of options outstanding at 30 June 2022 is 3.048 years Our Collaborators

RkJQdWJsaXNoZXIy MjE2NDg3